Presenting at the Mid-Atlantic Capital Conference in Philadelphia
Today, I had the privilege of presenting Calla Lily Clinical Care’s latest innovation, Callavid®, at the MidAtlantic Capital Conference with PACT in Philadelphia. It’s an exciting step forward in women’s health, particularly for those navigating the challenges of IVF and miscarriage. Our Callavid technology harnesses the power of intravaginal drug delivery initially through our medical …
A Look at Three Common Medications That Can Be Delivered Intravaginally
When one thinks about yeast infections, menopause and fertility support, the conversation usually revolves around pills or injections. But there’s a better, more targeted way to achieve results. The era of blanket treatments is fading. I used to joke that medicine isn’t Burger King–you can’t just have it your way. Except, that’s exactly what is …
Professor Andy Lewis presents at PODD 2024 in Boston
We had a great 2 days at the Partnerships in Drug Delivery PODD Conference in Boston with team members Professor Andrew Lewis and Dr Lara Zibners representing Calla Lily. Besides Andy’s well received presentation on our Callavid vaginal drug delivery platform, there were also superb connections made with the wider drug delivery technology community, and …
Why Intravaginal Drug Delivery Is the Future of Women’s Health
When we talk about advancements in healthcare, the vagina doesn’t often make it into the conversation. But it should. Hell, it’s standard dinner conversation at my house. The power of the vagina as a vessel for targeted, effective treatment is an emerging trend in women’s health. A trend geared toward smarter, safer, more effective medication …
Pitching at the Merck Innovation Challenge
What a privilege it was for Lara and I to present Calla Lily Clinical Care to senior members of Merck Group and M Ventures . Selected out of 100+ women’s health startups from around the world, we were able to share our vision for our transformational Callavid drug delivery platform, beginning with pregnancy & fertility. …
Pitching at the Merck Innovation Challenge
Many of you know my drive to co-found Calla Lily Clinical Care was driven by my personal journey as a infertility survivor. The memory that remains particularly vivid is the distress caused by the inadequate methods of administering progesterone— whether through injections, pessaries, tablets, or suppositories. Each option (including now rings) has its pros and …
Top 6 Takeaways from the Women’s Health Innovation Summit in Boston
I feel like Boston is the place to be these days! I made my 3rd trip there in the last year to attend the Women’s Health Innovation Summit in Boston thanks to Kisaco Research and it was inspiring, to say the least. The event assembled leaders, innovators, and passionate professionals all focused on one mission: …
Visit to MIT Center for Gynepathology Research
I had the great honour of meeting with Linda Griffith, Professor of Biological and Mechanical Engineering, and MacVicar Fellow at Massachusetts Institute of Technology, where she leads the MIT Center for Gynepathology Research. I’ve long been inspired by Professor Griffith’s groundbreaking work, and now, with our progress and dedicated team & lab resources in place, …
“Unlocking the Potential of the Vaginal Microbiome” panel at WHIS Boston
Our Co-Founder Dr Lara Zibners will be at the Women’s Health Innovation USA 2024 summit in Boston to talk about the exciting vaginal microbiome space as part of the panel “Unlocking the Potential of the Vaginal Microbiome”. The advancing science is becoming impossible to ignore: reproductive tract dysbiosis or the lack of a healthy vaginal …
Pitching at the New York Venture Summit
Just returned from another productive trip to New York, where I also had the chance to pitch our Callavid drug delivery technology at the New York Venture Summit hosted by Young Startup Ventures at the Javits Center. Beyond engaging with potential investors, it was inspiring to connect with fellow medtech founders and explore exciting new …